New York, December 21, 2023 – Palatin Technologies, Inc. (NYSE American: PTN) has completed the sale of Vyleesi® to Cosette Pharmaceuticals, a US-based, specialty pharmaceutical company, for up to $171 million. Vyleesi is the first and only as-needed FDA-approved treatment for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). Palatin Technologies, Inc. Carl Spana, Ph.D., President and … Continue reading “Palatin Technologies Sells Vyleesi in $171M Transaction”
Breaking News
SinglePoint CEO Releases Shareholder Letter Overviewing 2023 and Successful Listing on Cboe BZX Exchange
Successfully Uplisted to Cboe BZX Exchange December 15, 2023 Year to Date Revenue Crossing $30…
Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial
New York, December 21, 2023 – Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has received FDA clearance to conduct…
Clubhouse Media Group, Inc. Announces Separation from Agency to Focus Resources on HoneyDrip.com
LOS ANGELES, December 21, 2023 – Clubhouse Media Group, Inc. (OTC: CMGR) (“CMGR”), a social…
PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120%
New York, December 20, 2023 – PRISM MarketView, a leading provider of unbiased market insight…
PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success
New York, December 20, 2023 – Clinical-stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) is celebrating a year of…
Spooz, Inc. (SPZI) Completes Primary Acquisitions and Change of Control
Spooz Acquired Key JP Energy Assets; Vests Control to John K. Park Clearwater, FL., December…
Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership
New York, December 20, 2023 – Shares in payment network company, Affirm Holdings (Nasdaq: AFRM), jumped more…
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
–Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 – Lipella…
SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split
Phoenix, AZ, December 19, 2023 – SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a diversified…
NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment
New York, December 19, 2023 – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its…
PPJ Healthcare Enterprises, Inc. signed new Billing Accounts
TAMPA, FLORIDA, December 19, 2023 – PPJ Healthcare Enterprises Inc. (OTC Pink: PPJE) has announced…
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
POMPANO BEACH, FLORIDA, December 19, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative…
PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?
NEW YORK, NY, December 18, 2023 – Shares in Battalion Oil Corporation (NYSE American: BATL) surged more…
